enGene Holdings, Inc. (ENGN)
7.33
+0.09
(+1.24%)
USD |
NASDAQ |
Apr 07, 16:00
8.01
+0.68
(+9.28%)
After-Hours: 05:45
enGene Holdings EPS Diluted (Quarterly) : -0.4423 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2752 |
| Oncolytics Biotech, Inc. | -0.0139 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.75M |
| Total Expenses (Quarterly) | 29.75M |
| Enterprise Value | 248.48M |
| Earnings Yield | -30.33% |
| Normalized Earnings Yield | -30.26 |